Showing results 1 to 7 of 7
Title | Author(s) | Issue Date | |
---|---|---|---|
Low-dose pembrolizumab for relapsed/refractory Hodgkin lymphoma: high efficacy with minimal toxicity Journal:Annals of Hematology | 2017 | ||
PD1 blockade with low-dose nivolumab in NK/T cell lymphoma failing l-asparaginase: efficacy and safety Journal:Annals of Hematology | 2017 | ||
2017 | |||
Pembrolizumab and lenalidomide induced remission in refractory double-hit lymphoma Journal:Annals of Hematology | 2016 | ||
2016 | |||
2018 | |||
2010 |